Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin subunit beta (β-tubulin) is a highly conserved protein that, together with alpha-tubulin (α-tubulin), forms heterodimers which are the fundamental building blocks of microtubules. Microtubules are dynamic cytoskeletal structures essential for maintaining cell shape, enabling intracellular transport, and facilitating cell division in all eukaryotic cells. β-Tubulin pairs with α-tubulin to form protofilaments that assemble into microtubules. Several drugs target specific sites on β-tubulin dimers to inhibit cell division. Altered expression or mutation of certain tubulin beta isoforms has been implicated in tumorigenesis, which has made tubulins key targets for chemotherapeutic drug development.
Microtubule stabilization or destabilization, leading to disruption of cell division and intracellular transport.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin Subunit Beta (β-tubulin).